Sankar Subramanian 4
4 · Nautilus Biotechnology, Inc. · Filed Sep 19, 2022
Insider Transaction Report
Form 4
Sankar Subramanian
Senior VP, Product Development
Transactions
- Purchase
Common Stock
2022-09-15$2.19/sh+40,000$87,752→ 40,000 total - Purchase
Common Stock
2022-09-16$2.16/sh+35,000$75,446→ 75,000 total
Footnotes (2)
- [F1]Represents the weighted average share price of an aggregate total of 40,000 shares purchased in the price range of $2.145 to $2.2292 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 35,000 shares purchased in the price range of $2.10 to $2.21 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.